Bronchitol Drug Interactions: What to Avoid and What to Tell Your Doctor

If you've been prescribed Bronchitol (inhaled mannitol) for cystic fibrosis, you may wonder whether it interacts with your other medications. The short answer: no formal drug interaction studies have been conducted for inhaled Bronchitol, and there are no known clinically significant drug interactions with Bronchitol at this time. However, there are important context-specific considerations your CF care team needs to know about.

Bronchitol Drug Interaction Status: What the Research Says

According to the FDA-approved prescribing information: "No formal drug interaction studies have been conducted with mannitol, the active ingredient in BRONCHITOL." This means that while there are no known problematic interactions, comprehensive interaction data are also limited.

Mannitol is metabolized by a CYP-independent pathway (the glycolytic pathway via dehydrogenation to fructose) and is primarily eliminated via the kidneys. This means it does not interact with the CYP450 enzyme system that governs many common drug-drug interactions.

The One Major Rule: Do Not Use With Hypertonic Saline

The most clinically important interaction-like concern is not a drug interaction per se, but a contraindicated combination: Bronchitol should not be used concurrently with inhaled hypertonic saline. All three Bronchitol Phase 3 clinical trials excluded patients using hypertonic saline, so the safety and efficacy of using both at the same time have not been established.

Both Bronchitol and hypertonic saline work through osmotic mechanisms to draw water into the airways. Using both simultaneously could theoretically cause excessive airway dehydration or other unpredictable effects on airway mucus. Your CF care team will choose one or the other for your mucolytic regimen.

Required Co-medication: Short-Acting Bronchodilator

Bronchitol must always be taken 5–15 minutes after an inhaled short-acting bronchodilator (such as albuterol/salbutamol). This is not an interaction to avoid — it's a required co-administration. The bronchodilator opens the airways before each dose to reduce the risk of bronchospasm from the mannitol.

If you are already taking a long-acting bronchodilator (like salmeterol or tiotropium) as part of your CF regimen, you still need a separate short-acting bronchodilator before each Bronchitol dose. Long-acting bronchodilators do not substitute for the pre-dose requirement.

Medications Your CF Team Should Know You're Taking

While there are no confirmed pharmacokinetic drug interactions with Bronchitol, your CF care team should always have a full picture of everything you take. Tell them about:

All other inhaled CF medications: Including Pulmozyme (dornase alfa), TOBI (tobramycin), Cayston (aztreonam), Bethkis, and any CFTR modulators (Trikafta, Kalydeco, Orkambi, Symdeko)

Antibiotics: If you're taking oral or IV antibiotics (particularly tobramycin or other aminoglycosides), let your CF team know — while not a direct Bronchitol interaction, monitoring is important in CF patients on aminoglycosides due to nephrotoxicity risk from the drug class

Medications that affect kidney function: Since mannitol is primarily eliminated by the kidneys, patients with renal impairment may have increased systemic exposure. Formal pharmacokinetic studies have not been done in renally impaired patients.

Any new prescriptions or over-the-counter medications: Always update your CF team when you start any new medication, supplement, or herbal product

Pregnancy, Breastfeeding, and Bronchitol

There are no adequate and well-controlled studies of Bronchitol in pregnant women. Animal studies did not show structural fetal alterations at doses up to 10–20 times the maximum recommended human daily inhalation dose, but CF itself can increase the risk of preterm delivery. Use Bronchitol during pregnancy only if the benefit clearly justifies the potential risk.

It is not known whether Bronchitol passes into breast milk. Discuss breastfeeding decisions with your CF specialist.

What About Food and Alcohol?

There are no known interactions between Bronchitol and foods or drinks. The effect of alcohol on Bronchitol is not known, but moderate alcohol consumption is not expected to alter the local airway action of an inhaled dry powder. That said, always discuss alcohol consumption with your CF care team given broader CF management considerations.

For more on Bronchitol safety, see: Bronchitol Side Effects: What to Expect and When to Call Your Doctor.

For a full overview of Bronchitol, see: What Is Bronchitol? Uses, Dosage, and What You Need to Know in 2026.